Yizhe Wang
2021
In 2021, Yizhe Wang earned a total compensation of $19.5M as CEO; Director at LianBio.
Compensation breakdown
| Bonus | $240,000 |
|---|---|
| Non-Equity Incentive Plan | $460,685 |
| Option Awards | $18,090,944 |
| Salary | $312,500 |
| Stock Awards | $421,781 |
| Total | $19,525,910 |
Wang received $18.1M in option awards, accounting for 93% of the total pay in 2021.
Wang also received $240K in bonus, $460.7K in non-equity incentive plan, $312.5K in salary and $421.8K in stock awards.
Rankings
In 2021, Yizhe Wang's compensation ranked 343rd out of 12,415 executives tracked by ExecPay. In other words, Wang earned more than 97.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 343 out of 12,415 | 97th |
Division Manufacturing | 102 out of 5,505 | 98th |
Major group Chemicals And Allied Products | 32 out of 2,375 | 99th |
Industry group Drugs | 28 out of 2,096 | 99th |
Industry Pharmaceutical Preparations | 16 out of 1,546 | 99th |
Source: SEC filing on April 27, 2022.
Wang's colleagues
We found three more compensation records of executives who worked with Yizhe Wang at LianBio in 2021.